Seer, Inc.
SEERHealthcare|Biotechnology|US
$1.63
+0.00 (+0.00%)
Tangible Book / Share
$4.09
Cash / Share
$2.77
Clinical Trials (3)
| Trial | Conditions | Phase | Status | Enrollment | Design | Drug |
|---|---|---|---|---|---|---|
| NCT00219882 Safety Study of Orally Administered Curcuminoids in Adult Subjects With Cystic Fibrosis | Cystic Fibrosis | P1 | Completed | 11 | Open-label | standardized turmeric root extract |
| NCT03882671 Development of a Minimally Invasive Seizure Gauge | Epilepsy | N/A | Completed | 40 | Open-label | — |
| NCT03465189 Validation of a Seizure Monitoring System | Epilepsy | Completed | 10 | — | — |